Eli Lilly's Olumiant (baricitinib) receives positive European regulatory opinion for approval to treat adolescents with severe alopecia areata

Innovent Biologics' Jaypirca approved in China for new indication

FDA accepts sNDA for MR-141 for the treatment of presbyopia

Lupin's Brivaracetam Oral Solution approved by US FDA

Johnson & Johnson submits sBLA to FDA for first-ever treatment for wAIHA

AlzeCure's ACD440 granted EU orphan drug status for erythromelalgia

Armata Pharmaceuticals' AP-SA02 receives QIDP designation from US FDA

Immedica Pharma's Loargys (pegzilarginase-nbln) receives accelerated US FDA approval

Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH

Organon licenses MIUDELLA IUD from Sebela Pharmaceuticals

Gilead to acquire Arcellx to gain full control of anito-cel

Novo Nordisk's CagriSema achieves 23% weight loss but misses primary endpoint in REDEFINE 4 trial

AbbVie's VENCLEXTA (venetoclax) and acalabrutinib combination receives US FDA approval to treat CLL

Vanda Pharmaceuticals' BYSANTI (milsaperidone) tablets receive US FDA approval

FDA accepts Genentech application for giredestrant combination in ESR1-mutated advanced breast cancer